CVS Health is appointing David Joyner as the new chief executive, taking over from Karen Lynch. The company has faced financial challenges and a declining stock price, prompting the need for new leadership. Joyner will need to address issues within the Aetna health insurance business and navigate FTC scrutiny of pharmacy benefit managers. Meanwhile, Donald Trump has shifted away from his aggressive health policy agenda, leaving room for potential changes if he were to take office again. Former Trump White House official Joe Grogan highlights potential policy fights around drug pricing and Affordable Care Act subsidies. Trump’s previous proposals have been adjusted in response to Biden’s policy changes.
Source link
We’re reading about a new CVS chief, obesity meds cutting ODs
